Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.

Search

News

Technology sneak peek from Ascenion: Seven breakthrough life-science inventions

[Translate to English:]

Heidelberg Pharma AG is allowed to initiate a Phase I/IIa clinical study in the US to evaluate the dosing, safety and anti-tumour efficacy of its lead candidate HDP-101 in multiple myeloma.

[Translate to English:]

16 partners from academia and industry will closely collaborate to prepare a future generation of scientists with outstanding skills in both machine learning and chemistry, to create new AI methods for drug research.

[Translate to English:]

Ascenion, technology transfer partner of Hannover Medical School (MHH), has supported the conclusion of a collaboration and licence agreement between MHH and Novo Nordisk.

This year’s BioVaria is digital and takes place exclusively online from the 26 to 28 April 2021.

[Translate to English:]

In December 2020 the Ascenion team gained two new colleagues: Dr Sören Rindfleisch in Hanover and Hubert Ludwiczak in München.

[Translate to English:]

As part of its ‘GO-Bio initial’ programme, the BMBF has awarded Ascenion funding for its 'Life Science Digital Hub' concept to improve support for GO-Bio initial applicants.

[Translate to English:]

Merry Christmas!

We would like to thank all our clients, colleagues and partners in technology transfer, research and industry for the enjoyable and productive…

[Translate to English:]

Ascenion’s portfolio company HepaRegeniX achieves an important preclinical milestone indicating beneficial therapeutic effects of its lead candidate in certain liver carcinomas.

[Translate to English:]

An innovative approach to combat infections caused by Staphylococcus aureus will receive funding of initially 1.33 million USD plus an additional 7.44 million USD, depending on project progress. It is jointly developed by the HZI and the LDC.

[Translate to English:]

Ascenion’s portfolio company Cardior Pharmaceuticals announced positive results of a Phase Ib study with its first-in-class compound CDR132L.

[Translate to English:]

Ascenion welcomes a new colleague to the Munich office: Stefanie Danzer joined in October 2020 to support the back office in event management and corporate communications.

[Translate to English:]

Ascenion will support eight members and four partners of the Innovative Training Network (ITN) ‘SMABEYOND’ in all aspects relating to the intellectual property and potential commercialization of their work.

[Translate to English:]

Ascenion’s portfolio company iThera gained regulatory approval for a pivotal trial evaluating its MSOT imaging technology for the assessment of colon inflammation. If successful, it could provide a superior, non-invasive alternative to colonoscopy.

[Translate to English:]

How is the German start-up sector doing? Are there ‘zombies’ here too – as in the USA? And what should we be looking out for? A number of heads of German technology transfer organisations were interviewed for this overview, including Ascenion’s Christian Stein.

Events

[Translate to English:]

AUTM Annual Meeting 2021 Virtual

[Translate to English:]

BIO-Europe Spring Digital

[Translate to English:]

BioVaria 2021 Virtual

[Translate to English:]

ASTP Annual Conference 2021

Online

[Translate to English:]

BIO International Convention Digital